Monte Rosa Therapeutics (NASDAQ: GLUE)
$4.23
(-2.9%)
-$0.12
Price as of August 7, 2025, 4:00 p.m. ET
Monte Rosa Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Monte Rosa Therapeutics Company Info
Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.